Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lancet (London, England) (2022) - Comments
pubmed: 35065705  doi: 10.1016/s0140-6736(22)00055-1  issn: 0140-6736  issn: 1474-547x 

Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank Rockhold, Sue Ann Costa Clemens, Camilo Roa, Charissa Borja-Tabora, Antoinette Quinsaat, Pio Lopez, Eduardo López-Medina, Leonardo Brochado, Eder A Hernández, Humberto Reynales, Tatiana Medina, Hector Velasquez, Leonardo Bautista Toloza, Edith Johana Rodriguez, Dora Ines Molina De Salazar